1967
DOI: 10.1002/jps.2600561240
|View full text |Cite
|
Sign up to set email alerts
|

Absolute configurations of the enantiomeric pheniramines, methylphenidates, and pipradrols

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

1970
1970
2017
2017

Publication Types

Select...
3
3

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 10 publications
0
2
0
Order By: Relevance
“…First synthesized in 1944 and recognized as a stimulant in 1954, early chemical work is described primarily in the patent literature and was centered on the separation and interconversion of the so called (a) isomer and the biologically more active (b) isomer. The absolute (2 R ,2‘ R ; threo ) stereochemistry of the most active enantiomer of methylphenidate ( 1a ) was proven by chemical techniques. , A series of alkyl esters of (±)- threo -ritalinic acid was made in 1961 and shown to be less potent stimulants than 1a . In 1974 Faraj et al .…”
Section: Introductionmentioning
confidence: 99%
“…First synthesized in 1944 and recognized as a stimulant in 1954, early chemical work is described primarily in the patent literature and was centered on the separation and interconversion of the so called (a) isomer and the biologically more active (b) isomer. The absolute (2 R ,2‘ R ; threo ) stereochemistry of the most active enantiomer of methylphenidate ( 1a ) was proven by chemical techniques. , A series of alkyl esters of (±)- threo -ritalinic acid was made in 1961 and shown to be less potent stimulants than 1a . In 1974 Faraj et al .…”
Section: Introductionmentioning
confidence: 99%
“…[7][8][9][10] Subsequent studies focused on the separation of the two diastereomers and interconversion of (±)-erythro racemate to its (±)-threo counterpart. The (±)-threo racemate exists as two enantiomers, (+)-threo-MPH (2R,2'R) and (-)-threo-MPH (2S,2'S), and the absolute stereochemistry of the most pharmacologically active enantiomer of MPH ((+)-threo) has been characterized [11][12][13] and developed as a medication to treat ADHD in its own right. [14] There have also been efforts to prepare enantiomerically pure (2R,2'R)-(+)-threo-MPH.…”
Section: Introductionmentioning
confidence: 99%